The stock market braces for a big week for earnings, economic news and trade war issues. Apple, Amazon, Pfizer and Chevron ...

SGLT2 inhibitors and GLP-1 agonists are class 1 medications, but many Medicaid patients have challenges with access.

Alexandria Real Estate Equities may be a candidate for investors looking for a solid and secure dividend income.

Targeted at CMO executives, procurement leaders, and investors, the report addresses US tariffs, BRICS regulatory shifts, and key industry dynamics, ...

Eli Lilly's Orforglipron shines in Phase III trials, potentially leading diabetes and obesity treatment by 2026. See what to ...

WeightWatchers will file for bankruptcy in the coming weeks after finally negotiating a deal on its $1.6 billion of debt.